Skip to main content
. 2022 Sep 28;149(8):4611–4621. doi: 10.1007/s00432-022-04356-9

Fig. 3.

Fig. 3

Kaplan–Meier estimates of relapse-free survival (RFS, left) and overall survival (OS, right) for ELN 2017 favorable-risk AML patients after propensity score adjustment (A) and censored for allogeneic hematopoietic cell transplantation (HCT) in first complete remission (B)